购物车
- 全部删除
您的购物车当前为空
C18 3'-sulfo Galactosylceramide (d18:1/18:0)
产品编号 T38183Cas号 244215-65-4
别名 C18 3'-sulfo Galactosylceramide (d18:1/18:0)
C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD).
C18 3'-sulfo Galactosylceramide (d18:1/18:0)
产品编号 T38183 别名 C18 3'-sulfo Galactosylceramide (d18:1/18:0)Cas号 244215-65-4
C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 12,150 | 期货 |
大包装 & 定制
加入购物车
实验操作小课堂
查看更多 联系我们获取更多批次信息
资源下载
产品介绍
生物活性
化学信息
| 产品描述 | C18 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. Levels of short-chain sulfatides, including C18 3'-sulfo galactosylceramide, decrease with age in mice and humans. It is increased in brain from mice with an arylsulfatase A deficiency (ASA-KO), particularly in lipid raft fractions. Plasma levels of C18 3'-sulfo galactosylceramide positively correlate with disability progression in patients with relapsing-remitting multiple sclerosis using the Expanded Disability Status Scale. It is also increased in plasma from patients with metachromatic leukodystrophy (MLD). |
| 别名 | C18 3'-sulfo Galactosylceramide (d18:1/18:0) |
| 分子量 | 808.17 |
| 分子式 | C42H81NO11S |
| CAS No. | 244215-65-4 |
储存&溶解度
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度信息 | Chloroform:Methanol (5:1): Soluble |
计算器
体内实验配液计算器
请在以下方框中输入您的动物实验信息后点击计算，可以得到母液配置方法和体内配方的制备方法：
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
剂量转换
对于不同动物的给药剂量换算，您也可以参考 更多
关键词
预览
Related Tags: buy C18 3'-sulfo Galactosylceramide (d18:1/18:0) | purchase C18 3'-sulfo Galactosylceramide (d18:1/18:0) | C18 3'-sulfo Galactosylceramide (d18:1/18:0) cost | order C18 3'-sulfo Galactosylceramide (d18:1/18:0) | C18 3'-sulfo Galactosylceramide (d18:1/18:0) chemical structure | C18 3'-sulfo Galactosylceramide (d18:1/18:0) formula | C18 3'-sulfo Galactosylceramide (d18:1/18:0) molecular weight
嗨！很高兴为您提供帮助！
